MARKET

HQL

HQL

abrdn Life Sciences Investors
NYSE
13.92
-0.01
-0.07%
Closed 16:00 03/04 EST
OPEN
13.93
PREV CLOSE
13.93
HIGH
13.95
LOW
13.86
VOLUME
115.00K
TURNOVER
0
52 WEEK HIGH
14.37
52 WEEK LOW
11.03
TOTAL ASSET
440.20M
YTD YIELD
11.27%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at HQL last week (0226-0301)?
Weekly Report · 14h ago
Weekly Report: what happened at HQL last week (0219-0223)?
Weekly Report · 02/26 09:26
The abrdn Healthcare Opportunities Fund Is Due For A Breakout
Seeking Alpha · 02/20 16:00
Weekly Report: what happened at HQL last week (0212-0216)?
Weekly Report · 02/19 09:27
Weekly Report: what happened at HQL last week (0205-0209)?
Weekly Report · 02/12 09:24
abrdn Life Sciences Investors raises dividend by 30% to $0.39
Abrdn Life Sciences Investors raises dividend by 30% to $0.39. Forward yield 11.26% Payable March 28; for shareholders of record Feb. 22; ex-div Feb. 21. The company intends to maintain the increased Managed Distribution Policy for the next year.
Seeking Alpha · 02/12 07:30
Weekly Report: what happened at HQL last week (0129-0202)?
Weekly Report · 02/05 09:26
Weekly Report: what happened at HQL last week (0122-0126)?
Weekly Report · 01/29 09:24
More
Profile
Fund Name
abrdn Life Sciences Investors
Inception Date
1992-05-08
Benchmark
NASDAQ Biotechnology TR USD
Advisor Company
Tekla Capital Management LLC
Custodian
State Street Bank and Trust Co
Manager
Daniel Omstead